Concepedia

Sarah R. Klein

SR

12

Publications

1.3K

Citations

12

H-Index

1984

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

Brigham and Women's Hospital

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Sarah R. Klein is an author at Center for Drug Evaluation and Research specializing in medicine, autophagy, and cell biology.

Top concepts

Publications per year

1984–2021

12

Publications

12

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

David A. Reardon, Prafulla C. Gokhale, Sarah R. Klein et al. · Cancer Immunology Research · 2015 · 422 citations · Full text

The myth of serum albumin as a measure of nutritional status

Sarah R. Klein · Gastroenterology · 1990 · 159 citations

, , +11

The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase IIα in Breast Cancer Cells

V. Ashutosh Rao, Sarah R. Klein, Keli Agama et al. · Cancer Research · 2009 · 154 citations · Full text

The Antioxidant Transcription Factor Nrf2 Negatively Regulates Autophagy and Growth Arrest Induced by the Anticancer Redox Agent Mitoquinone

V. Ashutosh Rao, Sarah R. Klein, Spencer J. Bonar et al. · Journal of Biological Chemistry · 2010 · 134 citations · Full text

, , +17

Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.

Q.G.C.M. van Hoesel, Peter A. Steerenberg, Daan J.A. Crommelin et al. · PubMed · 1984 · 120 citations

, , +18

Rows per page

1–5 of 12